Minimally Invasive Surgery of the Gastro-esophageal Junction

Functional Assessment Following Minimally Invasive Surgery of the Gastro-Esophageal Junction

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01799967

Acronym

MISGEJ

Enrollment

200

Registered

2013-02-27

Start date

2007-11-01

Completion date

2027-11-01

Last updated

2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achalasia, Epiphrenic Diverticula, GERD, Paraesophageal Hernia, Zenker's Diverticulum

Keywords

gastro-esophageal junction, minimally invasive, Achalasia, Paraesophageal hernia, GERD, Epiphrenic diverticula, Zenker's diverticulum, All minimally invasive surgeries of the gastro-esophageal junction

Brief summary

This study will assess short and long term outcomes of individuals undergoing minimally invasive surgery of the gastro-esophageal junction (MISGEJ). Patients will respond to questionnaires on an annual basis evaluating quality of life and functionality following MISGEJ. Hospital charts will also be reviewed on an annual basis to assess patient health outcomes.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All patients at the Ottawa Hospital undergoing minimally invasive surgery of the GEJ

Exclusion criteria

* Less than 18 years of age.

Design outcomes

Primary

Measure	Time frame	Description
MISGEJ symptoms (subjective)	8 years	MISGEJ symptom questionnaire evaluated on an annual basis
Achalasia Disease Severity (subjective)	8 years	Achalasia Disease Severity questionnaire evaluated on an annual basis.
Diagnostic imaging	8 years	Patient x-rays, upper GI tests, Endoscopy, and/or CT scans will be assessed on an annual basis to objectively measure functionality and health status.

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORAndrew JE Seely, MD, PhD

Ottawa Hospital Research Institute

Outcome results